The McNeil Consumer Healthcare Division plant in Fort Washington closed in April 2010 because of manufacturing problems, but the recalls of products made before that date continue. The company has recalled certain lots of products containing Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps that were distributed in the United States and Puerto Rico. The batches were manufactured at the Fort Washington site, before it was closed, or at the company’s facility in Puerto Rico, which is still operating, according to the company.
Both plants, along with one in Lancaster, were cited for problems during an investigation by the U.S. Food and Drug Administration. McNeil is a division of Johnson & Johnson Inc. This is the fifth recall of McNeil products in 2011. Most this year involved some version of Tylenol, but particular batches of Benadryl and Sudafed also had problems. Consumers can get more information on each at www.mcneilproductrecall.com.
According to the company, the latest recall notice was aimed at retailers and wholesalers, where those product lots would likely be located. The lot numbers and UPC code are on the side of the carton. They are: Tylenol Cold Multi-Symptom Nighttime Rapid Release Gels 24 RR Gelcaps (AMA277, APA059, APA162, ASA025, APA237, ASA072, ASA208, BAA008; UPC – 300450395245); Tylenol Cold Multi-Symptom Rapid Release Gels Day/night 12+8 RR Gelcaps (AMF034, BAF005, BAF027, BCF080; UPC – 300450396204) and Tylenol Cold Multi-Symptom Rapid Release Gels Day/night 36+24 RR Gelcaps (BBF001, BCF060, BCF079; UPC – 300450396600).
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.